Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 367-371, January 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ichikawa, T.
Right arrow Articles by Shimazaki, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ichikawa, T.
Right arrow Articles by Shimazaki, J.

Progression and Selection in Heterogeneous Tumor Composed of Androgen-responsive Shionogi Carcinoma 115 and Its Autonomous Subline (Chiba Subline 2)1

Tomohiko Ichikawa, Susumu Akimoto, Isamu Hayata and Jun Shimazaki2

Department of Urology, School of Medicine, Chiba University [T. I., S. A., J. S.], Chiba-shi 280, and National Institute of Radiological Sciences [I. H.], Chiba-shi 260, Japan

Shionogi Carcinoma 115 (SC 115) is an androgen-dependent mouse tumor, and Chiba subline 2 (CS 2) is its androgen-independent subline which differs from SC 115 in cell size, amount of androgen receptors, and karyotype. To shed light on the mechanism of clonal selection of androgen-independent tumors, mixed tumors with SC 115 and CS 2 were prepared, and growth of these tumors was examined in vivo and in vitro. When the mixed tumor was transplanted in mice, CS 2 showed a predominant growth over SC 115. In a culture of mixed tumor cells, however, CS 2 showed no selective growth advantage. The suppressive interaction which occurred in vivo was due neither to transferable substances, nor to some immunological factor(s). It may be, at least partially, attributable to necrosis formation in SC 115, which developed with an increase in the size of the tumor.

1 Supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Education, Science, and Culture (62010012); from the Ministry of Health and Welfare (62-40); and for scientific research from the Ministry of Education, Science, and Culture (62480333), Japan.

2 To whom requests for reprints should be addressed.

Received 3/ 1/88. Revised 6/20/88. Revised 9/30/88. Accepted 10/10/88.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Watabe, H. Kuramochi, Y. Furuya, N. Inagaki, S. Seino, S. Kimura, and J. Shimazaki
Identification of Histone H2A.X as a Growth Factor Secreted by an Androgen-independent Subline of Mouse Mammary Carcinoma Cells
J. Biol. Chem., October 11, 1996; 271(41): 25126 - 25130.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.